You have reached your monthly allowance of 1 free premium articles from The Pharmaceutical Journal and Clinical Pharmacist. Sign in or register for free to access 2 more articles. Subscribe for full access to The Pharmaceutical Journal and Clinical Pharmacist and CPD modules.
Use the code0516EMSB2DP for 20% discount on our annual digital subscriptions.
The role of non-statin drugs, including ezetimibe, fibrates, bile acid binders, nicotinic acid derivatives, omega-3 fatty acid supplements and PCSK9 inhibitors, for the management of dyslipidaemia in adults.
Are you already a registered user or a member of the Royal Pharmaceutical Society?Sign in here
Subscribe for as little as £5, to gain full, unlimited access to the ultimate source of information and news on pharmacy and pharmaceutical sciences.Subscribe today
Alternatively, register for free to the site for access to an extra 2 premium articles for free.Register now.
Please contact The Pharmaceutical Journal directly, so we can provide you with detailed information about our institutional and corporate offerings.
Tel: +44 (0)20 7572 2221
As a pharmacist or pharmaceutical scientist, join the Royal Pharmaceutical Society and gain full access to pharmaceutical-journal.com
Membership is free for pharmacy students.
If you are not registered as a pharmacist in Great Britain or practise overseas, you may still be able to join the RPS as an associate member.Become a member